FDA Inspection 584391 — AbbVie Deutschland GmbH & Co. KG
The FDA completed an inspection of AbbVie Deutschland GmbH & Co. KG on May 15, 2009 in Ludwigshafen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 15, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ludwigshafen (Germany)